Volume 14, 2010

Sign On

Volume 14, 2010 CD
Six back issues from 2010 on one convenient CD.

Permanent storage and easy retrieval of IJPC articles and formulations.

Print journal articles in color from the PDF file for your marketing needs.
Eliminate long searches through past issues for formulations, compatibility studies, standard operating procedures, marketing ideas, and literature reviews.

Only $95 per CD

This CD contains the following articles listed by volume, issue and page number:


Issues Included
Volume/Issue	Date	Title
Vol. 14 No. 1	January/February 2010	Pediatrics and Wellness
Vol. 14 No. 2	March/April 2010	Compounding for Men
Vol. 14 No. 3	May/June 2010	Pain Management
Vol. 14 No. 4	July/August 2010	Sterile Compounding
Vol. 14 No. 5	September/October 2010	Supporting Quality Pharmaceutical Compounding World Wide
Vol. 14 No. 6	November/December 2010	Volume 14, Number 6

Volume 14, 2010 CD ARTICLES

Title (Click for Details)	Vol/Issue	Page

Volume 14, 2010 CD ARTICLES
PreScription: APhA and IJPC Working Together	Vol. 14 No. 1	4
PreScription: American Pharmacists Assocation and Compounding: New Partnership Reflects Old Ties	Vol. 14 No. 1	4
When Traditional Medicine Fails	Vol. 14 No. 1	6
Sleepless in America: Compounding with Melatonin	Vol. 14 No. 1	10
Prophylaxis Against Exposure to Bloodborne Pathogens During Compounding	Vol. 14 No. 1	14
Compounding Pharmacy: A Unique Service for a Unique Population	Vol. 14 No. 1	19
Calculating Carbohydrate Content of Compounded Medications for Patients on a Ketogenic Diet	Vol. 14 No. 1	21
Providing Consultation Services for Wellness Issues Related to Exercise, Weight Management, and Nutritional Support: Key Lifestyle Modification for Healthier Aging	Vol. 14 No. 1	26
Unit Dose Packaging and Repackaging of Solid and Liquid Dosage Forms in an Institutional Setting	Vol. 14 No. 1	32
Diverse Challenges in Pediatric Compounding: Treating Pulmonary Hypertension, Uncombable Hair Syndrome, and Acanthamoeba keratitis	Vol. 14 No. 1	40
An Academic Practice Partnership: An Innovative Course in Advanced Compounding	Vol. 14 No. 1	48
Literature Review & Importance of Quality Control	Vol. 14 No. 1	54
Calculations	Vol. 14 No. 1	58
Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmacy Compounding Sterile Preparations, Part 17: Elements of Quality Control	Vol. 14 No. 1	60
Hand Sanitizer Gel	Vol. 14 No. 1	66
Hydrocarbon-Free Lotion	Vol. 14 No. 1	67
Ketoprofen 100-mg/5-mL Mouth Rinse	Vol. 14 No. 1	68
Metronidazole in Normal Saline Enema	Vol. 14 No. 1	69
Ophthalmic Toning-Lubricating Drops	Vol. 14 No. 1	70
Solprotex 2.5% Lotion	Vol. 14 No. 1	71
Testosterone 1% in Alcoholic Gel	Vol. 14 No. 1	72
Tetracaine 4% and Menthol 5% Topical Gel	Vol. 14 No. 1	73
Tobramycin Sulfate 0.3% and Diclofenac Sodium 0.1% Ophthalmic Solution	Vol. 14 No. 1	74
Trigger Point Gel	Vol. 14 No. 1	75
Chemical Stability of Hydrocortisone in Humco Simple Syrup and Ora-Sweet Vehicle	Vol. 14 No. 1	76
Evaluation of a Simple Method for Visual Detection of Microprecipitates in Blends of Parenteral Drug Solutions Using a Focussed (Tyndall) Light Beam	Vol. 14 No. 1	78
Stability of Oseltamivir Phosphate in SyrSpend SF, Cherry Syrup, and SyrSpend SF (For Reconstitution)	Vol. 14 No. 1	82
Postscription: 2010 A New Year, New Commitments, and New Challenges	Vol. 14 No. 1	86
PreScription: The Ages of Man	Vol. 14 No. 2	92
PreScription: Changing the Game	Vol. 14 No. 2	92
Emerging Evidence for Androgen Replacement Therapy in Aging Men	Vol. 14 No. 2	94
Hormonal Influences in Prostate Cancer: An Update of a Complex Subject	Vol. 14 No. 2	100
Determining the Causes of Erectile Dysfunction: Can Medications Be a Double-Sided Sword?	Vol. 14 No. 2	105
Coenzyme Q10 Supplementation in the Treatment of Heart Disease	Vol. 14 No. 2	108
Case Report: The Use of Inhaled Cyclosporine to Treat Bronchiolitis Obliterans Syndrome in a Lung Transplant Patient	Vol. 14 No. 2	112
Developing a Tretinoin Oral Liquid for Patients Who Cannot Take Capsules	Vol. 14 No. 2	118
Inventory Information Approval System Certification and Flexible Spending Account Purchases: A New Year Brings Changes	Vol. 14 No. 2	124
Cop's Best Friend: Preventing the Illegal Distribution and Transportation of Prescription Drugs	Vol. 14 No. 2	131
Owning an In-Network Pharmacy and a Second Out-of-Network Pharmacy that Performs Compounding: Suggestions on How to Avoid Being Terminated from the Pharmacy Benefits Manager Network	Vol. 14 No. 2	134
Quality Control: From Record Keeping to Key Performance Indicators: Managing Quality in Compounding Pharmacies	Vol. 14 No. 2	136
Calculations	Vol. 14 No. 2	140
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 18: Verification of Automated Compounding Devices for Parenteral Nutrition Compounding and Finished Preparation Release Checks and Tests	Vol. 14 No. 2	142
Acyclovir 5% in Oral Adhesive Paste	Vol. 14 No. 2	150
Acyclovir 200-mg/5-mL Oral Suspension (From the Injection)	Vol. 14 No. 2	151
Ciclopirox 10% in Isopropyl Alcohol Nail Solution	Vol. 14 No. 2	152
Clotrimazole 1% Oral Adhesive Paste	Vol. 14 No. 2	153
Cyclosporin 10-mg/g in Oral Adhesive Paste	Vol. 14 No. 2	154
Dexpanthenol 5% Gel-Cream	Vol. 14 No. 2	155
Lamotrigine 25-mg/mL Injection	Vol. 14 No. 2	156
Metolazone 10-mg/mL Injection	Vol. 14 No. 2	157
Plasticized Hydrocarbon Gel	Vol. 14 No. 2	158
Oral Adhesive Paste	Vol. 14 No. 2	159
Chemical Stability of Hydromorphone Hydrochloride in Patient-Controlled Analgesia Injector	Vol. 14 No. 2	160
Menopausal Women's Access Path to Bioidentical Hormone Replacement Therapy: An Exploratory Study	Vol. 14 No. 2	165
Low Dose Naltrexone: Side Effects and Efficacy in Gastrointestinal Disorders	Vol. 14 No. 2	171
PostScription: Is Being Involved in the Pharmacy Student Preceptor Program Worth the Effort?	Vol. 14 No. 2	174
PreScription: Quality Improvement in Pharmaceutical Compounding	Vol. 14 No. 3	180
PreScription: Healthcare Reform Is Not All That Is Happening in Washington	Vol. 14 No. 3	180
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome	Vol. 14 No. 3	182
The Role of Sex Hormones on Fibromyalgia Pain Mediators	Vol. 14 No. 3	193
Topical Medications for Orofacial Neuropathic Pain	Vol. 14 No. 3	200
Managing Pain with Transdermal Ketoprofen	Vol. 14 No. 3	204
Potential Treatments for Radiation Dermatitis	Vol. 14 No. 3	210
Compounding Gabapentin Suspension for Lower Back Pain in an Older Cat: A Case Report	Vol. 14 No. 3	215
Quality Control Analytical Methods: Continuous Quality Improvement	Vol. 14 No. 3	218
Basics of Compounding: Compounding with Hydrates and Solvates	Vol. 14 No. 3	222
Calculations	Vol. 14 No. 3	230
Basics of Compounding: Considerations for Implementing USP Chapter <797> -- Sterile Preparations, Part 19: Storage and Beyond-Use Dating, Maintaining Sterility, Purity, and Stability of Dispensed and Distributed Compounded Sterile Preparations	Vol. 14 No. 3	232
Bacitracin 10,000-Units/mL Ophthalmic Solution	Vol. 14 No. 3	240
Carprofen 2.5-mg/mL Oral Suspension, Veterinary	Vol. 14 No. 3	241
Celecoxib 10-mg/mL Oral Suspension	Vol. 14 No. 3	242
Clozapine 20-mg/mL Oral Suspension	Vol. 14 No. 3	243
Cohen's Rectal Ointment	Vol. 14 No. 3	244
Cyclophosphamide 10-mg/mL Oral Suspension	Vol. 14 No. 3	245
Lansoprazole 3-mg/mL Oral Suspension	Vol. 14 No. 3	246
Rifaximin 20-mg/mL Oral Suspension	Vol. 14 No. 3	247
Sunitinib 10-mg/mL Oral Suspension	Vol. 14 No. 3	248
Voriconazole 40-mg/mL Oral Suspension, Veterinary	Vol. 14 No. 3	249
Compounding Rifampin Suspensions with Improved Injectability for Nasogastric Enteral Feeding Tube Administration	Vol. 14 No. 3	250
Weight Uniformity of Scored Tablet Halves Manufactured by Palestinian Pharmaceutical Companies	Vol. 14 No. 3	257
PostScription: Healthcare Reform and Compounding Issues	Vol. 14 No. 3	262
PreScription: Beginning of a New United States Pharmacopeial Convention, Inc., Cycle	Vol. 14 No. 4	268
PreScription: Sterile Product Outsourcing: Growing Trend in Hospitals	Vol. 14 No. 4	268
Developing an Erythromycin Ophthalmic Ointment: Putting the Puzzle Pieces Together	Vol. 14 No. 4	270
Recommendations for Compounding Medications for Feeding Tube Administration	Vol. 14 No. 4	276
Hygrometers and Thermohygrometers: Environmental Monitoring Ensures the Potency and Stability of Compounding Agents	Vol. 14 No. 4	284
Considerations for Percutaneous Absorption	Vol. 14 No. 4	301
Thyroid Potency Calculations	Vol. 14 No. 4	306
Unique Challenges in Compounding: Managing Severe Musculoskeletal Pain in a Recovered Substance Abuser	Vol. 14 No. 4	310
Quality Control Analytical Methods: Pharmacopeial Bacterial Endotoxins Test Chapters	Vol. 14 No. 4	317
Basics of Compounding: Basics of Compounding with Organic Salts	Vol. 14 No. 4	322
Calculations	Vol. 14 No. 4	327
Basics of Compounding: Considerations for Implementing USP Chapter <797> Pharmacy Compounding -- Sterile Preparations, Part 20: Patient or Caregiver Training, Patient Monitoring and Adverse Events Reporting, and Quality-Assurance Program	Vol. 14 No. 4	328
Acyclovir with Benzocaine Lip Balm	Vol. 14 No. 4	332
Acyclovir 5% Lip Balm with Dioxybenzone and Oxybenzone	Vol. 14 No. 4	333
Amitriptyline Hydrochloride Suppositories	Vol. 14 No. 4	334
Ampicillin 250-mg Suppository	Vol. 14 No. 4	335
Antazoline Phosphate and Xylometazoline Hydrochloride Ophthalmic Drops	Vol. 14 No. 4	336
Buprenorphine Hydrochloride Injection	Vol. 14 No. 4	337
Chloroprocaine Hydrochloride Injection	Vol. 14 No. 4	338
Cyanocobalamin, Choline, and Niacinamide Injection	Vol. 14 No. 4	339
Fenoldopam Mesylate Injection	Vol. 14 No. 4	340
Flurbiprofen 5% Bioadhesive Gel for Gingivitis	Vol. 14 No. 4	341
Evaluation of Extemporaneous Oral Itraconazole Suspensions by Dissolution Profiles Mapping	Vol. 14 No. 4	342
Compatibility and Stability of Cefotaxine, Vancomycin, and Ciprofloxacin in Antibiotic Lock Solutions Containing Heparin	Vol. 14 No. 4	346
PostScription: Innovative Community Pharmacy Practice: Past, Present, and Future	Vol. 14 No. 4	350
PreScription: Revised Format	Vol. 14 No. 5	358
PreScription: Compounding Veterinary Products: Needed but Problematic	Vol. 14 No. 5	358
Home Infusion Accreditation: Another Quality Recognition Branding Tool	Vol. 14 No. 5	360
Community Pharmacy Addresses the Need for Proper Drug Disposal with Positive Response	Vol. 14 No. 5	366
Implementation of a Viable Air-Sampling Program Using a Volumetric Collection Device	Vol. 14 No. 5	370
Bioidentical Hormones in the News	Vol. 14 No. 5	374
Conservative Management of Chronic Kidney Disease in Cats: Recommendations for Veterinarians and Compounding Pharmacists	Vol. 14 No. 5	382
Tetracaine Lollipops for the Suppression of Extreme Gag Reflex in Dental Patients	Vol. 14 No. 5	395
Development of a Standardized Intranet Database of Formulation Records for Nonsterile Compounding, Part 1	Vol. 14 No. 5	401
Quality Control Analytical Methods: Endotoxins: Essential Testing for Pyrogens in the Compounding Laboratory, Part 1	Vol. 14 No. 5	407
Basics of Compounding: Basics of Compounding with Esters	Vol. 14 No. 5	416
Calculations	Vol. 14 No. 5	419
Alpha-Bisabolol Mouthwash	Vol. 14 No. 5	420
Three Fortified Ophthalmic Solutions: Amikacin 5% Ophthalmic Solution; Ceftazidime 5% Ophthalmic Solution; Vancomycin 5% Ophthalmic Solution	Vol. 14 No. 5	421
Icy Blue Camphorated Gel	Vol. 14 No. 5	422
Carvedilol 1-mg/mL Oral Suspension	Vol. 14 No. 5	423
Buspirone 2.5-mg/mL Oral Suspension	Vol. 14 No. 5	424
Triclosan 0.28% Mouthwash	Vol. 14 No. 5	425
Rufinamide 40-mg/mL Oral Suspension	Vol. 14 No. 5	426
Haloperidol 0.416-mg/mL, Hyoscine 4.9-mg/mL, and Tramadol 16.67-mg/mL in 0.9% Sodium Chloride Injection	Vol. 14 No. 5	427
Panitumumab 2.5-mg/mL in 0.9% Sodium Chloride Injection	Vol. 14 No. 5	428
Polidocanol 0.5% Wound Spray	Vol. 14 No. 5	429
Quality Control and Physical and Chemical Stability of Hydrocortisone Oral Suspension: An Interlaboratory Study	Vol. 14 No. 5	430
Stability and Compatibility of Reconstituted Caspofungin in Select Elastomeric Infusion Device	Vol. 14 No. 5	436
PostScription: Guidance to Achieve Accreditation from the Pharmacy Compounding Accreditation Board	Vol. 14 No. 5	440
PreScription: Compounding with Manufactured Products	Vol. 14 No. 6	448
Home Infusion: Overcoming the Barriers to Entry	Vol. 14 No. 6	450
In the Hands of Your Enemy	Vol. 14 No. 6	456
The Clinical Use of Dehydroepiandrosterone in Postmenopausal Women	Vol. 14 No. 6	465
Extemporaneous Compounding of Medicated Ointment	Vol. 14 No. 6	472
"My Hip Hurts": A Collaboration of Clinicians in the Treatment of Adhesive Capsulitis to Optimize Patient Care	Vol. 14 No. 6	480
All-Purpose Nipple Ointment: A Compounding Solution to Common Problems with Breastfeeding	Vol. 14 No. 6	484
Case Report: Management of Secondary Hypertension in a Feline with the Use of Transdermal Prazosin	Vol. 14 No. 6	488
Quality-Control Analytical Methods: Endotoxins: Essential Testing for Pyrogens in the Compounding Laboratory, Part 2	Vol. 14 No. 6	493
Basics of Compounding: Basics of Compounding with Aliquots, Dilutions, and Concentrates	Vol. 14 No. 6	508
Calculations	Vol. 14 No. 6	511
Amitriptyline Hydrochloride 2%, Baclofen 5%, Ketamine Hydrochloride 5%, Ketoprofen 10% in Pluronic Lecithin Organogel	Vol. 14 No. 6	512
Baclofen 5%, Capcaicin 0.075%, Ketoprofen 10%, and Tetracaine 2% in Pluronic Lecithin Organogel	Vol. 14 No. 6	513
Baclofen 5%, Gabapentin 5%, Ketoprofen 10%, and Lidocaine 5% in Pluronic Lecithin Organogel	Vol. 14 No. 6	514
Bromazepam 2.5-mg/mL Drops	Vol. 14 No. 6	515
Bromhexine Hydrochloride 0.8-mg/mL Syrup	Vol. 14 No. 6	516
Capsaicin 0.05% Clear Medication Stick	Vol. 14 No. 6	517
Glutathione 25% in Pluronic Lecithin Organogel	Vol. 14 No. 6	518
Gramicidin 13% Ophthalmic Solution	Vol. 14 No. 6	519
Ketoprofen 5% and Lidocaine Hydrochloride 0.5% Topical Gel	Vol. 14 No. 6	520
Ketoprofen 2% Oral Gel	Vol. 14 No. 6	521
Stability of Methimazole in Poloxamer Lecithin Organogel to Determine Beyond-Use Date	Vol. 14 No. 6	522
Barrier Isolator/Glovebox Glove Dexterity Study	Vol. 14 No. 6	526
PostScription: Profile of a Pharmacy Compounding Accreditation Board Accredited Pharmacy: Avera Doctors Plaza 2 Pharmacy	Vol. 14 No. 6	531